Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 6/20 | 0.84 |
| ▸ | PDE3A | Q14432 | 6/20 | 0.84 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.84 |
| ▸ | MAOA | P21397 | 1/20 | 0.84 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.84 |
| ▸ | GPR119 | Q8TDV5 | 9/20 | 0.61 |
| ▸ | PDE4A | P27815 | 2/20 | 0.58 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.58 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.58 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | F10 | P00742 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pimobendan SCHEMBL29386190 | 1.00 | PDE3B (0.84) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL27623 | 1.00 | PDE3B (0.84) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL15617988 | 1.00 | PDE3B (0.84) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL2466855 | 1.00 | PDE3B (0.84) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL668129 | 0.99 | PDE3B (0.83) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL1996787 | 0.99 | PDE3B (0.83) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL1997246 | 0.98 | PDE3B (0.81) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL1993626 | 0.95 | PDE3B (0.77) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL1649737 | 0.92 | PDE3B (1.00) | PDE3BPDE3AABCB11MAOAADORA2A | |
| SCHEMBL9781454 | 0.87 | PDE3B (0.64) | PDE3BPDE3AABCB11MAOAADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3318247-A1 | TASTE MASKED PHARMACEUTICAL COMPOSITION | Boehringer Ingelheim Vetmedica GmbH (DE) | 2018-05-09 | — | — | EP | claimed |
| EP-2741736-B1 | TASTE MASKED PHARMACEUTICAL COMPOSITION | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2017-11-22 | — | — | EP | claimed |
| US-20140227351-A1 | TASTE MASKED PHARMACEUTICAL COMPOSITION | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2014-08-14 | — | — | US | claimed |
| US-8741350-B2 | Taste masked pharmaceutical composition | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2014-06-03 | — | — | US | claimed |
| US-20130084332-A1 | TASTE MASKED PHARMACEUTICAL COMPOSITION | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2013-04-04 | — | — | US | claimed |
| EP-2825159-B1 | PHARMACEUTICAL TABLET FORMULATION FOR THE VETERINARY MEDICAL SECTOR, METHOD OF PRODUCTION AND USE THEREOF | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2022-06-22 | — | — | EP | disclosed |
| US-11357855-B2 | Liquid formulation | Luoda Pharma Limited (IE) | 2022-06-14 | — | — | US | disclosed |
| CN-109568253-B | Liquid preparation | 罗达制药有限公司 | 2022-04-26 | — | — | CN | disclosed |
| EP-3167876-B1 | PHARMACEUTICAL TABLET FORMULATION FOR THE VETERINARY MEDICAL SECTOR, METHOD OF PRODUCTION AND USE THEREOF | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2021-09-08 | — | — | EP | disclosed |
| EP-3682902-A1 | LIQUID FORMULATION | Luoda Pharma Limited (IE) | 2020-07-22 | — | — | EP | disclosed |
| EP-2849792-B1 | LIQUID FORMULATION | LUODA PHARMA LTD (IE) | 2020-03-04 | — | — | EP | disclosed |
| US-10413610-B2 | Liquid formulation | Luoda Pharma Limited (IE) | 2019-09-17 | — | — | US | disclosed |
| US-9808529-B2 | Liquid formulation | LUODA PHARMA PTY LTD (AU) | 2017-11-07 | — | — | US | disclosed |
| EP-3167876-A1 | PHARMACEUTICAL TABLET FORMULATION FOR THE VETERINARY MEDICAL SECTOR, METHOD OF PRODUCTION AND USE THEREOF | Boehringer Ingelheim Vetmedica GmbH (DE) | 2017-05-17 | — | — | EP | disclosed |
| US-9289390-B2 | Taste masked pharmaceutical composition | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2016-03-22 | — | — | US | disclosed |
| US-20150148335-A1 | LIQUID FORMULATION | Luoda Pharma Limited (IE) | 2015-05-28 | — | — | US | disclosed |
| US-20150064249-A1 | PHARMACEUTICAL TABLET FORMULATION FOR THE VETERINARY MEDICAL SECTOR, METHOD OF PRODUCTION AND USE THEREOF | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2015-03-05 | — | — | US | disclosed |
| US-20140227351-A1 | TASTE MASKED PHARMACEUTICAL COMPOSITION | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2014-08-14 | — | — | US | disclosed |
| US-8741350-B2 | Taste masked pharmaceutical composition | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2014-06-03 | — | — | US | disclosed |
| US-20130084332-A1 | TASTE MASKED PHARMACEUTICAL COMPOSITION | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2013-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150148335-A1 | LIQUID FORMULATION | ACE, AGTR1, AGT | PDE3B 40/4885PDE3A 34/4885ABCB11 1969/4885 |
| US-10413610-B2 | Liquid formulation | ACE, AGTR1, AGT | PDE3B 40/4885PDE3A 34/4885ABCB11 1969/4885 |
| US-11357855-B2 | Liquid formulation | ACE, AGTR1, AGT | PDE3B 40/4885PDE3A 34/4885ABCB11 1969/4885 |
| US-20150064249-A1 | PHARMACEUTICAL TABLET FORMULATION FOR THE VETERINARY MEDICAL SECTOR, METHOD OF PRODUCTION AND USE THEREOF | ACE, PIGS, ACE2 | PDE3B 1008/4885PDE3A 582/4885ABCB11 34/4885 |
| US-20130084332-A1 | TASTE MASKED PHARMACEUTICAL COMPOSITION | TAS2R50, TAS2R40, TAS2R42 | PDE3B 779/4885PDE3A 579/4885ABCB11 765/4885 |
| US-20140227351-A1 | TASTE MASKED PHARMACEUTICAL COMPOSITION | TAS2R50, TAS2R40, TAS2R30 | PDE3B 985/4885PDE3A 674/4885ABCB11 842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.